Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13150)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 8, 2016 (publication date) through Apr 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rapisarda V, Loreto C, Malaguarnera M, Ardiri A, Proiti M, Rigano G, Frazzetto E, Ruggeri MI, Malaguarnera G, Bertino N, Malaguarnera M, Catania VE, Di Carlo I, Toro A, Bertino E, Mangano D, Bertino G. Hepatocellular carcinoma and the risk of occupational exposure. World J Hepatol 2016; 8(13): 573-590 [PMID: 27168870 DOI: 10.4254/wjh.v8.i13.573] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i13/573.htm |
| Number | Citing Articles |
| 1 |
Ségolène Bouet, Eric Samson, Iris Jovanovic, Dominique Laurier, Olivier Laurent. First mortality analysis in the French cohort of uranium millers (F-Millers), period 1968–2013. International Archives of Occupational and Environmental Health 2018; 91(1): 23 doi: 10.1007/s00420-017-1254-7
|
| 2 |
Şeyda KARABÖRK, Gamze DOĞDU, Turgay PEKDEMİR. Cytotoxic Efficacy of Indigo and Yellow 2G with Vitamin C on the HepG2 Cell Line. International Journal of Nature and Life Sciences 2023; 7(1): 1 doi: 10.47947/ijnls.1237640
|
| 3 |
Chawin Srisomwat, Prinjaporn Teengam, Natthaya Chuaypen, Pisit Tangkijvanich, Tirayut Vilaivan, Orawon Chailapakul. Pop-up paper electrochemical device for label-free hepatitis B virus DNA detection. Sensors and Actuators B: Chemical 2020; 316: 128077 doi: 10.1016/j.snb.2020.128077
|
| 4 |
Ekaterina Zhuravleva, Colm J. O’Rourke, Jesper B. Andersen. Mutational signatures and processes in hepatobiliary cancers. Nature Reviews Gastroenterology & Hepatology 2022; 19(6): 367 doi: 10.1038/s41575-022-00587-w
|
| 5 |
Silvia Marchese, Andrea Polo, Andrea Ariano, Salvatore Velotto, Susan Costantini, Lorella Severino. Aflatoxin B1 and M1: Biological Properties and Their Involvement in Cancer Development. Toxins 2018; 10(6): 214 doi: 10.3390/toxins10060214
|
| 6 |
Shuaizhou Chen, Yao Chen, Qufei Qian, Xuewei Wang, Yuting Chang, Sihan Ju, Yide Xu, Chang Zhang, Na Qin, Hui Ding, Yayun Gu, Jing Han, Cheng Wang, Erbao Zhang, Zhibin Hu. Gene amplification derived a cancer‐testis long noncoding RNA PCAT6 regulates cell proliferation and migration in hepatocellular carcinoma. Cancer Medicine 2019; 8(6): 3017 doi: 10.1002/cam4.2141
|
| 7 |
Giulia Malaguarnera, Vito Emanuele Catania, Antonio Francaviglia, Michele Malaguarnera, Filippo Drago, Massimo Motta, Saverio Latteri. Lipoprotein(a) in patients with hepatocellular carcinoma and portal vein thrombosis. Aging Clinical and Experimental Research 2017; 29(S1): 185 doi: 10.1007/s40520-016-0653-z
|
| 8 |
Hongwei Zhang, Zhibin Liao, Weijian Wang, Yachong Liu, He Zhu, Huifang Liang, Bixiang Zhang, Xiaoping Chen. A micropeptide JunBP regulated by TGF-β promotes hepatocellular carcinoma metastasis. Oncogene 2023; 42(2): 113 doi: 10.1038/s41388-022-02518-0
|
| 9 |
Jian Zhang, Fangxi Xue, Shuhua Chen, Dongqin Zhang, Cuihong Lu, Gongen Tang. The influence of caveolin-1 gene polymorphisms on hepatitis B virus-related hepatocellular carcinoma susceptibility in Chinese Han population. Medicine 2017; 96(42): e7359 doi: 10.1097/MD.0000000000007359
|
| 10 |
Fadime TONBAK, Pelin DEMİR. YEM VE GIDALARLA HAYATIMIZA GİREN AFLATOKSİNLERİ ÖNLEME YÖNTEMLERİ. Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni 2021; 12(2): 105 doi: 10.38137/vftd.966325
|
| 11 |
Eka Noviana, Tugba Ozer, Cody S. Carrell, Jeremy S. Link, Catherine McMahon, Ilhoon Jang, Charles S. Henry. Microfluidic Paper-Based Analytical Devices: From Design to Applications. Chemical Reviews 2021; 121(19): 11835 doi: 10.1021/acs.chemrev.0c01335
|
| 12 |
Jing-Hong Hu, Mei-Yen Chen, Chau-Ting Yeh, Wen-Nan Chiu, Ming-shih Chiang, Ming-Ling Chang. Effects of gender and age on prevalence of cholelithiasis in patients with chronic HCV infection. Medicine 2018; 97(22): e10846 doi: 10.1097/MD.0000000000010846
|
| 13 |
Amanda E Janitz, Gurumurthy Ramachandran, Gail E Tomlinson, Mark Krailo, Michaela Richardson, Logan Spector. Maternal and paternal occupational exposures and hepatoblastoma: results from the HOPE study through the Children’s Oncology Group. Journal of Exposure Science & Environmental Epidemiology 2017; 27(4): 359 doi: 10.1038/jes.2017.1
|
| 14 |
Yen-Ju Chen, Chih-Jung Shen, Shao-Hua Yu, Cheng-Li Lin, Hong-Mo Shih. Increased risk of hepatocellular carcinoma in patients with traumatic liver injury. Medicine 2022; 101(6): e28837 doi: 10.1097/MD.0000000000028837
|
| 15 |
Xuejing Yang, Dong Song, Junping Zhang, Xuejing Yang, Huijing Feng, Jianian Guo. PRR34-AS1 sponges miR-498 to facilitate TOMM20 and ITGA6 mediated tumor progression in HCC. Experimental and Molecular Pathology 2021; 120: 104620 doi: 10.1016/j.yexmp.2021.104620
|
| 16 |
Qi Xiao, BiQi Fu, Ping Chen, Zhong Zhong Liu, Wei Wang, QiFa Ye. Three polymorphisms of tumor necrosis factor-alpha and hepatitis B virus related hepatocellular carcinoma. Medicine 2016; 95(50): e5609 doi: 10.1097/MD.0000000000005609
|
| 17 |
Ramasamy Thilagavathi, S. Sameema Begum, Sowfika Dharshini Varatharaj, Arun kumar Balasubramaniam, Joselin Susan George, Chelliah Selvam. Recent insights into the hepatoprotective potential of medicinal plants and plant‐derived compounds. Phytotherapy Research 2023; 37(5): 2102 doi: 10.1002/ptr.7821
|
| 18 |
Wenpeng Zhao, Jiang Guo, Honglu Li, Liang Cai, Youjia Duan, Xiaopu Hou, Zhenying Diao, Xihong Shao, Hongliu Du, Changqing Li. RETRACTED ARTICLE: FAM83H-AS1/miR-485-5p/MEF2D axis facilitates proliferation, migration and invasion of hepatocellular carcinoma cells. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08923-0
|
| 19 |
Faezeh Sharafi, Sadegh Abaei Hasani, Samira Alesaeidi, Mohammad Saeed Kahrizi, Ali Adili, Shadi Ghoreishizadeh, Navid Shomali, Rozita Tamjidifar, Ramin Aslaminabad, Morteza Akbari. A comprehensive review about the utilization of immune checkpoint inhibitors and combination therapy in hepatocellular carcinoma: an updated review. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02682-z
|
| 20 |
Massimo Colombo, Carlo La Vecchia, Marcello Lotti, M. Isabel Lucena, Christophe Stove, Valérie Paradis, Philip Newsome. EASL Clinical Practice Guideline: Occupational liver diseases. Journal of Hepatology 2019; 71(5): 1022 doi: 10.1016/j.jhep.2019.08.008
|
| 21 |
Divya Jain, Pracheta Janmeda. Exposure, formation, and various available treatments to combat hepatocellular carcinoma: A comprehensive review. The Applied Biology & Chemistry Journal 2023; : 69 doi: 10.52679/tabcj.2023.0007
|
| 22 |
Wafaa M. Rashed, Mohamed Ahmed Mohamed Kandeil, Mohamed O. Mahmoud, Sameera Ezzat. Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview. Journal of the Egyptian National Cancer Institute 2020; 32(1) doi: 10.1186/s43046-020-0016-x
|
| 23 |
Jianchu Wang, Jian Pu, Tianwei Yao, Xiaojie Lu, Yibin Deng. Four long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma. Journal of Cellular Physiology 2019; 234(6): 8709 doi: 10.1002/jcp.27530
|
| 24 |
Chung-Feng Huang, Ming-Lun Yeh, Cing-Yi Huang, Pei-Chien Tsai, Yu-Min Ko, Kuan-Yu Chen, Zu-Yau Lin, Shinn-Cherng Chen, Chia-Yen Dai, Wan-Long Chuang, Jee-Fu Huang, Ming-Lung Yu. Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy. Medicine 2016; 95(27): e4157 doi: 10.1097/MD.0000000000004157
|
| 25 |
Jinfeng Bai, Ming Huang, Jinmei Zhou, Bohan Song, Jianjie Hua, Rong Ding. Development of a predictive nomogram for postembolization syndrome after transcatheter arterial chemoembolization of hepatocellular carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-53711-y
|
| 26 |
Francesco Tovoli, Bernardo Stefanini, Daniele Mandrioli, Stefano Mattioli, Andrea Vornoli, Daria Sgargi, Fabiana Manservisi, Fabio Piscaglia, Stefania Curti, Luigi Bolondi. Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: A prospective pilot study. Digestive and Liver Disease 2024; 56(4): 571 doi: 10.1016/j.dld.2023.12.007
|
| 27 |
Srinivas Namuduri, Rama Rao Malla, Jagadeeswara Rao Kakarla, Gopamma Daka. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 135 doi: 10.1016/B978-0-323-98806-3.00015-5
|
| 28 |
Giulia Malaguarnera, Gaetano Bertino, Carmela Greco, Caterina Gagliano, Massimo Motta, Giuseppe Chisari, Venerando Rapisarda, Giuseppe Nunnari, Michele Vecchio, Filippo Drago, Michele Malaguarnera. Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study. Translational Medicine Communications 2017; 2(1) doi: 10.1186/s41231-016-0010-4
|
| 29 |
Saverio Latteri, Giulia Malaguarnera, Vito Emanuele Catania, Gaetano La Greca, Gaetano Bertino, Antonio Maria Borzì, Filippo Drago, Michele Malaguarnera. Homocysteine Serum Levels as Prognostic Marker of Hepatocellular Carcinoma with Portal Vein Thrombosis. Current Molecular Medicine 2019; 19(7): 532 doi: 10.2174/1566524019666190610120416
|
| 30 |
Francesca Gorini, Elisa Bustaffa, Davide Bolignano, Liliana Cori, Francesco Faita, Amalia Gastaldelli, Monica Interdonato, Fabizio Minichilli, Giancarlo Quattrone, Francesco Squadrito, Giovanni Tripepi, Cristina Vassalle, Fabrizio Bianchi. Biomarkers of exposure and early effect in three contaminated sites of southern Italy: protocols for etiological epidemiological studies. BMJ Open 2020; 10(5): e036160 doi: 10.1136/bmjopen-2019-036160
|
| 31 |
Shuangjiang Chen, Runkun Liu, Hao Wang, Qingguang Liu. Hypoxia-driven miR-1307–3p promotes hepatocellular carcinoma cell proliferation and invasion by modulating DAB2 interacting protein. Pathology - Research and Practice 2022; 237: 154066 doi: 10.1016/j.prp.2022.154066
|
| 32 |
Tsung-Yu Tsai, Che-Chen Lin, Cheng-Yuan Peng, Wen-Hsin Huang, Wen-Pang Su, Shih-Wei Lai, Hsuan-Ju Chen, Hsueh-Chou Lai. The association between biliary tract inflammation and risk of digestive system cancers. Medicine 2016; 95(31): e4427 doi: 10.1097/MD.0000000000004427
|
| 33 |
Gaetano Bertino, Giulia Malaguarnera, Evelise Frazzetto, Alice Sciuto, Gaetano Inserra, Guido Nicola Zanghì, Michele Malaguarnera. Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions. World Journal of Hepatology 2018; 10(6): 448-451 doi: 10.4254/wjh.v10.i6.448
|
| 34 |
Mariangela Malaguarnera, Vito Emanuele Catania, Antonio Maria Borzì, Stefano Malaguarnera, Roberto Madeddu, Gaetano Bertino, Saverio Latteri. Blood homocysteine levels are increased in hepatocellular carcinoma patients with portal vein thrombosis. A single centre retrospective cohort study. International Journal of Surgery Open 2018; 15: 60 doi: 10.1016/j.ijso.2018.11.001
|
| 35 |
Meng Xue, Xiaona Lin, Qiu‐Xiong Lin, Xiaoyong Pu, Jiumin Liu, Xing‐Fang Li, Jun Hou, Xudong Liu, Ren Chen. Association between hepatitis B and E virus infection and hepatocellular carcinoma risk. International Journal of Cancer 2021; 148(12): 2974 doi: 10.1002/ijc.33505
|
| 36 |
Di Qu, Feng Cui, Dan Lu, Yu Yang, Yuqing Xu. DEP domain containing 1 predicts prognosis of hepatocellular carcinoma patients and regulates tumor proliferation and metastasis. Cancer Science 2019; 110(1): 157 doi: 10.1111/cas.13867
|
| 37 |
Yu-Gang Wang, Tao Wang, Min Shi, Bo Zhai. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1128-9
|
| 38 |
Federica Teglia, Giulia Collatuzzo, Paolo Boffetta. Occupational Cancers among Employed Women: A Narrative Review. Cancers 2023; 15(4): 1334 doi: 10.3390/cancers15041334
|
| 39 |
Giulia Malaguarnera, Gaetano Bertino, Giuseppe Chisari, Massimo Motta, Michele Vecchio, Marco Vacante, Filippo Caraci, Carmela Greco, Filippo Drago, Giuseppe Nunnari, Michele Malaguarnera. Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability. BMC Psychiatry 2016; 16(1) doi: 10.1186/s12888-016-1115-z
|
| 40 |
Jinfeng Bai, Ming Huang, Bohan Song, Wei Luo, Rong Ding. The Current Status and Future Prospects for Conversion Therapy in the Treatment of Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2023; 22: 153303382311597 doi: 10.1177/15330338231159718
|
| 41 |
Jafar Ai, Neda Ketabchi, Javad Verdi, Nematollah Gheibi, Hossein Khadem Haghighian, Maria Kavianpour. Mesenchymal stromal cells induce inhibitory effects on hepatocellular carcinoma through various signaling pathways. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-1038-0
|
| 42 |
Chen Jin, Chuan Li, Wei Peng, Tian-Fu Wen, Lv-Nan Yan, Bo Li, Wen-Tao Wang, Jia-Yin Yang, Ming-Qing Xu. Changes of platelet times neutrophil to lymphocyte ratio predict BCLC stage A hepatocellular carcinoma survival. Medicine 2017; 96(33): e7821 doi: 10.1097/MD.0000000000007821
|
| 43 |
Ahmed Al-khazraji. Cutaneous manifestations of hepatocellular cancer (HCC). Expert Review of Gastroenterology & Hepatology 2016; 10(10): 1075 doi: 10.1080/17474124.2016.1229182
|
| 44 |
Giulia Selvolini, Giovanna Marrazza. MIP-Based Sensors: Promising New Tools for Cancer Biomarker Determination. Sensors 2017; 17(4): 718 doi: 10.3390/s17040718
|
| 45 |
Xing-Zhi-Zi Wang. Aflatoxin B1 Occurrence, Detection and Toxicological Effects. 2020; doi: 10.5772/intechopen.90403
|
| 46 |
Di Wu, Yun‐Xuan Guan, Chen‐Hao Li, Quan Zheng, Zuo‐Jing Yin, Hui Wang, Ning‐Ning Liu. “Nutrient–fungi–host” tripartite interaction in cancer progression. iMeta 2024; 3(2) doi: 10.1002/imt2.170
|
| 47 |
William A. Suk, Vajarabhongsa Bhudhisawasdi, Mathuros Ruchirawat. The Curious Case of Cholangiocarcinoma: Opportunities for Environmental Health Scientists to Learn about a Complex Disease. Journal of Environmental and Public Health 2018; 2018: 1 doi: 10.1155/2018/2606973
|
| 48 |
Lihua Wang, Lijie Han, Zheying Tao, Zheng Zhu, Lei Han, Zhenfei Yang, Hao Wang, Dandan Dai, Liang Wu, Zhengzhong Yuan, Tongke Chen. The curcumin derivative WZ35 activates ROS-dependent JNK to suppress hepatocellular carcinoma metastasis. Food & Function 2018; 9(5): 2970 doi: 10.1039/C8FO00314A
|
| 49 |
Dong Sun, Jinghui Lu, Chunxiao Hu, Qiangbo Zhang, Xiangdong Wang, Zongli Zhang, Sanyuan Hu. Prognostic role of miR‑760 in hepatocellular carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.9546
|
| 50 |
Chawin Srisomwat, Abdulhadee Yakoh, Natthaya Chuaypen, Pisit Tangkijvanich, Tirayut Vilaivan, Orawon Chailapakul. Amplification-free DNA Sensor for the One-Step Detection of the Hepatitis B Virus Using an Automated Paper-Based Lateral Flow Electrochemical Device. Analytical Chemistry 2021; 93(5): 2879 doi: 10.1021/acs.analchem.0c04283
|
| 51 |
Jing Xie, Aihua Zhang, Xijun Wang. Metabolomic applications in hepatocellular carcinoma: toward the exploration of therapeutics and diagnosis through small molecules. RSC Advances 2017; 7(28): 17217 doi: 10.1039/C7RA00698E
|
| 52 |
Ahmet E. Atay, Bennur Esen, Emel S. Gokmen. Gastrointestinal Tissue. 2017; : 29 doi: 10.1016/B978-0-12-805377-5.00003-5
|
| 53 |
Jiwei Zhang, Zhe Li, Longzi Liu, Qifeng Wang, Shengli Li, Di Chen, Zhixiang Hu, Tao Yu, Jie Ding, Jinjun Li, Ming Yao, Shenglin Huang, Yingjun Zhao, Xianghuo He. Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin‐6/STAT3 signaling pathway. Hepatology 2018; 67(1): 171 doi: 10.1002/hep.29405
|
| 54 |
Fatema Abu-bakr Abdelmoez, Hala Mostafa Imam, Naglaa Kamal Idriss, Lobna Abdel Wahid, Wael Ahmed Abbas, Mohamed Abozaid Ali Abozaid, Hossam Mahmoud Abdelwahab. The Role of Hepatitis C virus and Possible Risk factors in development of Hepatocellular carcinoma: 400 Patients based study. The Egyptian Journal of Internal Medicine 2019; 31(1): 64 doi: 10.4103/ejim.ejim_50_18
|
| 55 |
Ji Zhao, Hong‐Qiang Chen, Hui‐Fang Yang, Xiao‐Yu Li, Wen‐Bin Liu. Gene expression network related to DNA methylation and miRNA regulation during the process of aflatoxin B1‐induced malignant transformation of L02 cells. Journal of Applied Toxicology 2022; 42(3): 475 doi: 10.1002/jat.4233
|
| 56 |
Chengxu Sui, Chengjun Zhuang, Deguang Sun, Li Yang, Liang Zhang, Lei Song. Notch1 regulates the JNK signaling pathway and increases apoptosis in hepatocellular carcinoma. Oncotarget 2017; 8(28): 45837 doi: 10.18632/oncotarget.17434
|
| 57 |
Nisha Sahu, Samrat Rakshit, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 33 doi: 10.1016/B978-0-323-98806-3.00023-4
|
| 58 |
Hamideh Tayefinasrabadi, Seyed Reza Mohebbi, Seyed Masoud Hosseini, Pedram Azimzadeh, Mohamad Amin Pourhoseingholi, Amir Ghaemi, Afsaneh Sharifian, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali. Association of Interleukin-17 gene polymorphisms with susceptibility to chronic hepatitis B virus infection and clearance in Iranian population. Microbial Pathogenesis 2020; 144: 104195 doi: 10.1016/j.micpath.2020.104195
|
| 59 |
Amir Najafi, Behzad Behnam, Elham Jafari, Hussein Anani, Somayyeh Karami-Mohajeri. Aminoguanidine induced apoptosis in human hepatocarcinoma HepG2 cells. Gene Reports 2021; 25: 101329 doi: 10.1016/j.genrep.2021.101329
|
| 60 |
Wenyi Liu, Lingqiao Wang, Chuanfen Zheng, Lebin Liu, Jia Wang, Daibo Li, Yao Tan, Xilong Zhao, Lixiong He, Weiqun Shu. Microcystin-LR increases genotoxicity induced by aflatoxin B1 through oxidative stress and DNA base excision repair genes in human hepatic cell lines. Environmental Pollution 2018; 233: 455 doi: 10.1016/j.envpol.2017.10.067
|